leuprolide and HIV-Associated-Lipodystrophy-Syndrome

leuprolide has been researched along with HIV-Associated-Lipodystrophy-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for leuprolide and HIV-Associated-Lipodystrophy-Syndrome

ArticleYear
Tumor-level serum testosterone associated with human immunodeficiency virus lipodystrophy syndrome.
    Obstetrics and gynecology, 2004, Volume: 103, Issue:5 Pt 2

    Human immunodeficiency virus (HIV) lipodystrophy syndrome consists of insulin resistance, hyperlipidemia, increased waist-to-hip ratios, and relative hyperandrogenemia, which resembles polycystic ovary syndrome.. A 30-year-old HIV-positive multipara with lipodystrophy syndrome had an elevated level of serum total testosterone (244 ng/dL) in the tumor range.. In HIV lipodystrophy syndrome, marked elevations of total serum testosterone in the range reserved for androgen-producing tumors may occur. The elevated testosterone levels are derived from the ovary and are responsive to gonadotropin suppression.

    Topics: Adult; Female; HIV-Associated Lipodystrophy Syndrome; Humans; Injections, Intramuscular; Leuprolide; Ovary; Testosterone

2004